ANI PHARMACEUTICALS, INC Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
ANI PHARMACEUTICALS, INC (ANIP) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $0 as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2014-02-28
- 2013-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-09-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2013-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2012-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $4.07M; Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) as first filed $4.07M.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) as first filed |
|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-02-28 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $4.07M 10-K · filed 2014-02-28 | $4.07M 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |